3 days popular7 days popular1 month popular3 months popular

Insulin resistance in bone disrupts whole-body glucose homeostasis

Insulin signaling in osteoblasts mediates the activation of , which promotes insulin secretion in the pancreas and in other tissues. It is unknown if develops in bone in response to a high fat diet (HFD) and contributes to the disruption of glucose metabolism associated with the development of type 2 diabetes.

In this issue of the , Gerard Karsenty and colleagues of Columbia University determined that insulin resistance does develop in osteoblasts of mice fed a HFD and that this insulin resistance in bone cells contribute to the development of whole-body glucose intolerance through decreased circulation of active osteocalcin.

Osteoblast-specific insulin resistance resulted, in part, from increased ubiquitination and degradation of the insulin receptor in response to saturated fatty acids. In the accompanying Commentary, Ryan Riddle and Thomas Clemens of Johns Hopkins University indicate that understanding the interplay between the skeletal system and whole-body metabolism will be beneficial for a wide range of metabolic diseases.


Bone-specific insulin resistance disrupts whole-body glucose homeostasis via decreased osteocalcin activation

Accompanying commentary:

Insulin, osteoblasts, and energy metabolism: why bone counts calories


JCI online ahead of print, March 18, 2014

Journal of Clinical Investigation